SE8902629D0 - Ny anvaendning av b-receptorblockerare - Google Patents

Ny anvaendning av b-receptorblockerare

Info

Publication number
SE8902629D0
SE8902629D0 SE8902629A SE8902629A SE8902629D0 SE 8902629 D0 SE8902629 D0 SE 8902629D0 SE 8902629 A SE8902629 A SE 8902629A SE 8902629 A SE8902629 A SE 8902629A SE 8902629 D0 SE8902629 D0 SE 8902629D0
Authority
SE
Sweden
Prior art keywords
pct
receptor blockers
new use
sec
date
Prior art date
Application number
SE8902629A
Other languages
English (en)
Other versions
SE8902629L (sv
SE464275B (sv
Inventor
F Aust
Original Assignee
Aagerup Bengt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aagerup Bengt filed Critical Aagerup Bengt
Priority to SE8902629A priority Critical patent/SE464275B/sv
Publication of SE8902629D0 publication Critical patent/SE8902629D0/sv
Priority to DE1990601070 priority patent/DE69001070T2/de
Priority to CA002033975A priority patent/CA2033975C/en
Priority to EP90911829A priority patent/EP0439570B1/en
Priority to US07/671,794 priority patent/US5128341A/en
Priority to AU60621/90A priority patent/AU629672B2/en
Priority to PCT/SE1990/000504 priority patent/WO1991001725A1/en
Priority to JP2510954A priority patent/JPH06501914A/ja
Publication of SE8902629L publication Critical patent/SE8902629L/sv
Publication of SE464275B publication Critical patent/SE464275B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
SE8902629A 1989-07-31 1989-07-31 Ny anvaendning av beta-receptorblockerare foer beredning av ett preparat verksamt mot menieres sjukdom SE464275B (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE8902629A SE464275B (sv) 1989-07-31 1989-07-31 Ny anvaendning av beta-receptorblockerare foer beredning av ett preparat verksamt mot menieres sjukdom
DE1990601070 DE69001070T2 (de) 1989-07-31 1990-07-25 Verwendung von beta-blockierungsmitteln zur behandlung der meniere-krankheit.
CA002033975A CA2033975C (en) 1989-07-31 1990-07-25 Use of .beta.-receptor blocking agents
EP90911829A EP0439570B1 (en) 1989-07-31 1990-07-25 A novel use of beta-receptor blocking agents for treatment of menieres' disease
US07/671,794 US5128341A (en) 1989-07-31 1990-07-25 Use of β-receptor blocking agents
AU60621/90A AU629672B2 (en) 1989-07-31 1990-07-25 A novel use of beta -receptor blocking agents for treatment of menieres' disease
PCT/SE1990/000504 WO1991001725A1 (en) 1989-07-31 1990-07-25 A NOVEL USE OF β-RECEPTOR BLOCKING AGENTS FOR TREATMENT OF MENIERES' DISEASE
JP2510954A JPH06501914A (ja) 1989-07-31 1990-07-25 β―レセプター遮断剤の新規な使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8902629A SE464275B (sv) 1989-07-31 1989-07-31 Ny anvaendning av beta-receptorblockerare foer beredning av ett preparat verksamt mot menieres sjukdom

Publications (3)

Publication Number Publication Date
SE8902629D0 true SE8902629D0 (sv) 1989-07-31
SE8902629L SE8902629L (sv) 1991-02-01
SE464275B SE464275B (sv) 1991-04-08

Family

ID=20376602

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8902629A SE464275B (sv) 1989-07-31 1989-07-31 Ny anvaendning av beta-receptorblockerare foer beredning av ett preparat verksamt mot menieres sjukdom

Country Status (7)

Country Link
US (1) US5128341A (sv)
EP (1) EP0439570B1 (sv)
JP (1) JPH06501914A (sv)
AU (1) AU629672B2 (sv)
CA (1) CA2033975C (sv)
SE (1) SE464275B (sv)
WO (1) WO1991001725A1 (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1156043E (pt) * 1992-07-24 2004-03-31 Univ California Drogas que aumentam as respostas sinapticas mediadas por receptores de ampa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3149034A (en) * 1961-07-17 1964-09-15 Umimed Inc Method of relieving pain with (pyridyllower alkyl)-amines
US4428883A (en) * 1981-03-06 1984-01-31 The University Of Kentucky Research Foundation Novel method of administering β-blockers and novel dosage forms containing same
IT1201136B (it) * 1987-01-13 1989-01-27 Resa Farma Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation

Also Published As

Publication number Publication date
EP0439570A1 (en) 1991-08-07
CA2033975A1 (en) 1991-02-01
WO1991001725A1 (en) 1991-02-21
AU629672B2 (en) 1992-10-08
EP0439570B1 (en) 1993-03-10
SE8902629L (sv) 1991-02-01
AU6062190A (en) 1991-03-11
US5128341A (en) 1992-07-07
JPH06501914A (ja) 1994-03-03
SE464275B (sv) 1991-04-08
CA2033975C (en) 1993-10-26

Similar Documents

Publication Publication Date Title
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
DE3774918D1 (de) Cancerostatisches mittel.
ATE342728T1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
DE69129302T2 (de) Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen
NO177526C (no) Fremgangsmåte for fremstilling av farmasöytisk aktive konjugater
ES2038650T3 (es) Procedimiento para preparar una composicion farmaceutica que comprende 3'-desoxitimidin-2'-eno-(3'-desoxi-2',3'-dideshidrotimidina) para tratar pacientes infectados con retrovirus.
DE69013999D1 (de) Siliconkautschukzusammensetzung zur Behandlung von Faserstrukturen.
SE8701656L (sv) Skyddsmanschett
ATE123024T1 (de) 4-aminopyridinderivate.
DE69701346T2 (de) Verwendung von siliciumhaltigen Verbindungen zum Färben von Menschlichen Keratinfasern; neue Verbindungen und Zusammensetzungen, die diese enthalten.
DK455088D0 (da) Syntetiske receptoranaloger
ES2135722T3 (es) 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina.
SE8902629L (sv) Ny anvaendning av b-receptorblockerare
DK178188A (da) Antivirusmiddel
ATE133417T1 (de) Antibakterielle trizyklische (6,5,5>/(6,6,5>kondensierte oxazolidinone
DE69921530D1 (de) Behandlung einer Virusinfektion bei Schweinen
BR8906377A (pt) Agente para a fixacao do penteado e para o tratamento dos cabelos
ATE107165T1 (de) Verwendung von macrolactonen als antiallergica.
MX9201288A (es) Metodo de tratamiento.
SE9404438D0 (sv) New process
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
DE69001070T2 (de) Verwendung von beta-blockierungsmitteln zur behandlung der meniere-krankheit.
ATE65394T1 (de) Behandlung von knochenschwund.
ATE65776T1 (de) Textilbehandlungsmittel.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8902629-8

Format of ref document f/p: F

NUG Patent has lapsed